Platelet-Rich Plasma vs. Corticosteroid for Partial-Thickness Tears of the Supraspinatus Tendon .
Effects of Platelet-Rich Plasma in Tear Size Reduction in Partial-Thickness Tear of the Supraspinatus Tendon Compared to Corticosteroids Injection.
Sports Med Open. 2023 Feb 8;9(1): 11.Thirty patients with partial-thickness tears of the supraspinatus tendon were randomized to receive a platelet-rich plasma injection (n=15) or corticosteroid injection (n=15). The primary outcome of interest was tear size. The secondary outcome of interest was functional outcomes, measured with the American Shoulder and Elbow Surgeons (ASES) score and the Constant Murley (CM) score. Outcomes were measured at 6 months post-injection. The improvement from baseline in tear size at 6 months in the coronal and sagittal views was significantly greater in the platelet-rich plasma group. Similarly, ASES and CM scores at 6 months were in favour of the platelet-rich plasma group.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
0 of 4 monthly FREE articles unlocked
